- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05092139
Endovascular treatmenT for Acute Ischemic Stroke in China (DETECT2-China)
February 21, 2024 updated by: Hui-Sheng Chen, General Hospital of Shenyang Military Region
enDovascular trEatmenT for acutE isChemic sTroke in China (DETECT2-China): a Prospective, National, Multi-center, Registry Study
This is a prospective real world registry study, aiming to explore the effectiveness and safety of endovascular treatment of acute ischemic stroke in a Chinese population.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
3000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Liaoning
-
ShenYang, Liaoning, China, 110840
- Recruiting
- Hui-Sheng Chen
-
Contact:
- Hui-Sheng Chen, Ph.D
- Phone Number: +8624897511
- Email: chszh@aliyun.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
acute ischemic stroke with large vessel oclussion
Description
Inclusion Criteria:
- Age: ≥ 18;
- Ischemic stroke confirmed by head CT or MRI;
- Patients receiving endovascular treatment;
- First ever stroke or pre-stroke mRS≤2;
- signed informed consent.
Exclusion Criteria:
- Prestroke mRS≥3;
- Other serious illness that would confound the clinical outcome at 90 days;
- Unavailable neuroimaging data;
- Other unsuitable conditions judged by the investigator
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of patients with modified Rankin Score 0 to 2
Time Frame: Day 90
|
the minimum and maximum values of modified Rankin Score are 0 and 6, respectively; higher score mean a worse outcome
|
Day 90
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of patients with modified Rankin Score 0 to 1
Time Frame: Day 90
|
the minimum and maximum values of modified Rankin Score are 0 and 6, respectively; higher score mean a worse outcome
|
Day 90
|
Distribution of modified Rankin Score
Time Frame: Day 90
|
the minimum and maximum values of modified Rankin Score are 0 and 6, respectively; higher score mean a worse outcome
|
Day 90
|
Changes in National Institute of Health stroke scale (NIHSS)
Time Frame: 24 hours, 48 hours, and 2 weeks
|
the minimum and maximum values of NIHSS are 0 and 24, respectively; higher NIHSS mean a worse outcome
|
24 hours, 48 hours, and 2 weeks
|
Proportion of symptomatic intracranial hemorrhage (sICH)
Time Frame: 48 hours
|
sICH was defined as 4 or more increase in NIHSS caused by hemorrhage
|
48 hours
|
Proportion of death
Time Frame: 7 days
|
death due to any cause
|
7 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
neuroimaging associated with clinical outcome
Time Frame: 48 hours
|
neuroimaging included brain CT, MRI or digital subtraction angiography
|
48 hours
|
changes in serum biomarkers
Time Frame: 48 hours
|
biomarker included Matrix metalloproteinases, proinflammatory cytokines, and etc.
|
48 hours
|
dynamic changes of TCD data associated
Time Frame: 24 hours
|
transcranial Doppler (TCD) data including blood velocity and pulse index, which will be collected at some centers
|
24 hours
|
dynamic changes of cortical blood oxygen saturation by near infrared spectroscopy
Time Frame: 24 hours
|
The data will be collected at some centers
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 21, 2022
Primary Completion (Estimated)
December 30, 2024
Study Completion (Estimated)
December 30, 2024
Study Registration Dates
First Submitted
October 13, 2021
First Submitted That Met QC Criteria
October 13, 2021
First Posted (Actual)
October 25, 2021
Study Record Updates
Last Update Posted (Estimated)
February 23, 2024
Last Update Submitted That Met QC Criteria
February 21, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- y (2021) 077
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke, Ischemic
-
Nordsjaellands HospitalRigshospitalet, Denmark; Metropolitan University CollegeCompletedTransient Ischemic Attack | Stroke, Ischemic | Stroke HemorrhagicDenmark
-
University of CalgaryThe George Institute for Global Health, AustraliaNot yet recruitingAcute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke AcuteCanada, Australia
-
Second Affiliated Hospital, School of Medicine,...Shanghai Zhongshan Hospital; First Affiliated Hospital of Wenzhou Medical University and other collaboratorsRecruitingAcute Ischemic Stroke and Transient Ischemic AttacksChina
-
Medtronic Cardiac Rhythm and Heart FailureMedtronic Bakken Research CenterCompletedCryptogenic Symptomatic Transient Ischemic Attack | Cryptogenic Ischemic StrokeNetherlands, United States, France, Belgium, Germany, Sweden, Italy, Austria, Canada, Denmark, Finland, Greece, Slovakia, Spain
-
University Hospital, BrestCompletedStroke, Ischemic | Stroke HemorrhagicFrance
-
Umbria Bioengineering TechnologiesRecruitingStroke, Ischemic | Stroke HemorrhagicItaly
-
Sheffield Teaching Hospitals NHS Foundation TrustUnknownFatigue | Stroke, Ischemic | Stroke HemorrhagicUnited Kingdom
-
BayerRecruitingAcute Non-cardioembolic Ischemic Stroke | Prevention of Ischemic Stroke | High-risk Transient Ischemic AttackUnited States, Switzerland, Belgium, Australia, Sweden, Canada, Taiwan, Spain, Korea, Republic of, Latvia, Israel, Malaysia, China, Greece, Japan, Turkey, Netherlands, Romania, United Kingdom, Portugal, Hungary, Italy, Brazil, France, S... and more
-
University of AlbertaCompletedTransient Ischemic Attack | Minor Ischemic StrokeCanada
-
Stephanie HarrisonActive, not recruitingTransient Ischemic Attack | Stroke, IschemicUnited Kingdom
Clinical Trials on endovascular treatment
-
Cook Research IncorporatedCompleted
-
Oslo University HospitalRecruiting
-
First People's Hospital of HangzhouShanghai Zhongshan Hospital; RenJi Hospital; Chengdu University of Traditional... and other collaboratorsRecruitingSafety Issues | Efficacy, Self | Lower Extremity Problem | Thromboembolic Disease | Endovascular TreatmentChina
-
Qingdao Hiser Medical GroupNot yet recruitingCommon Femoral Artery Occlusive Disease
-
RenJi HospitalChengdu University of Traditional Chinese Medicine; Xuanwu Hospital, Beijing; Zhejiang University and other collaboratorsRecruitingFemoropopliteal Occlusive DiseaseChina
-
Yonsei UniversityRecruitingPeripheral Arterial Disease(PAD)Korea, Republic of
-
Xuanwu Hospital, BeijingNational Key Research and Development Project, ChinaCompletedStroke, Ischemic | Intracranial AtherosclerosisChina
-
MicroPort NeuroTech Co., Ltd.Active, not recruiting
-
Hyogo College of MedicineCompletedMechanical Thrombectomy | Large Ischemic CoreJapan
-
Hyogo College of MedicineCompleted